Streetbeat News

Analyst Ratings

NVO

BMO Capital analyst Evan David Seigerman maintains an Outperform rating on Novo Nordisk (NYSE:NVO) but lowers the price target from $160 to $156.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:57 pm

CCI

Jefferies analyst Jonathan Petersen maintains a Buy rating on Crown Castle (NYSE:CCI) and raises the price target from $123 to $127.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:56 pm

GILD

BMO Capital analyst Evan Seigerman maintains an Outperform rating on Gilead Sciences and raises the price target from $85 to $94.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:56 pm

SYF

Jefferies analyst John Hecht has maintained a Buy rating on Synchrony Financial (NYSE:SYF) and raised the price target from $60 to $65.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:53 pm

BIIB

BMO Capital analyst Evan Seigerman maintains an Outperform rating on Biogen (NASDAQ:BIIB) but lowers the price target from $260 to $230.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:53 pm

ABBV

BMO Capital analyst Evan David Seigerman maintains an Outperform rating on AbbVie and raises the price target from $214 to $220.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:51 pm

ABT

Jefferies analyst Matthew Taylor maintains a Hold rating on Abbott Laboratories (NYSE:ABT) and raises the price target from $120 to $125.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:47 pm

LCID

Lucid Group (NASDAQ:LCID) has seen a surge in options activity, with a significant portion of investors adopting a bullish stance. The stock is currently trading at $2.85, down 13.11%, and is considered oversold. Analysts have set an average price target of $3.75, with recent downgrades to Neutral ratings.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 1:47 pm

META

Deep-pocketed investors are showing significant interest in Meta Platforms (NASDAQ:META) options, with a mix of bullish and bearish sentiments. The options activity suggests a potential price window of $545 to $700. Analysts have mixed ratings, with price targets ranging from $525 to $811.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 1:47 pm

AA

BMO Capital analyst Katja Jancic maintains a Market Perform rating on Alcoa (NYSE:AA) and raises the price target from $42 to $45.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:46 pm